Adicet Bio, Inc.

NasdaqCM:ACET Stock Report

Market Cap: US$73.3m

Adicet Bio Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:ACET Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
08 Oct 25BuyUS$5,000,000OrbiMed Advisors LLCCompany312,500US$16.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ACET?
Owner TypeNumber of SharesOwnership Percentage
Public Companies60,5110.599%
Individual Insiders84,4740.836%
VC/PE Firms1,027,94610.2%
General Public2,440,50224.1%
Institutions6,492,87464.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 78%.

Top Shareholders

Top 25 shareholders own 76.54% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
37.1%
The Goldman Sachs Group, Inc.
3,751,617US$27.2m1,500%0.01%
10.2%
OrbiMed Advisors LLC
1,027,946US$7.5m43.7%0.1%
6.2%
Franklin Resources, Inc.
626,571US$4.5m0%no data
5.09%
Tang Capital Management, LLC
513,975US$3.7m0%0.11%
4.66%
RA Capital Management, L.P.
471,312US$3.4m0%0.03%
2.88%
The Vanguard Group, Inc.
291,277US$2.1m42.4%no data
1.82%
Abingworth LLP
184,294US$1.3m0%2.04%
1.4%
Acadian Asset Management LLC
141,593US$1.0m9.2%no data
1.13%
Renaissance Technologies LLC
114,309US$828.7k58.5%no data
0.6%
Regeneron Pharmaceuticals, Inc.
60,511US$438.7k0%no data
0.56%
Bridgeway Capital Management, LLC
56,350US$408.5k0%0.01%
0.53%
Aya Jakobovits
53,541US$388.2k0%no data
0.53%
Two Sigma Investments, LP
53,410US$387.2k66.7%no data
0.48%
Two Sigma Advisers, LP
48,811US$353.9k38%no data
0.44%
Geode Capital Management, LLC
44,145US$320.1k0%no data
0.41%
Alyeska Investment Group, L.P.
40,979US$297.1k0%no data
0.38%
RBF Capital LLC
38,582US$279.7k0%0.01%
0.36%
BlackRock, Inc.
36,586US$265.2k-2.35%no data
0.36%
Citadel Advisors LLC
36,496US$264.6k26.8%no data
0.35%
Millennium Management LLC
35,372US$256.4k-4.45%no data
0.3%
Schonfeld Strategic Advisors LLC
29,944US$217.1k-74.5%no data
0.23%
Johnson & Johnson Innovation - JJDC, Inc.
22,779US$165.1k0%0.03%
0.19%
WealthEdge Investment Advisors LLC
18,753US$136.0k-4.17%0.05%
0.19%
Barclays Bank PLC
18,750US$135.9k100%no data
0.18%
GSA Capital Partners LLP
17,763US$128.8k0%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/10 11:37
End of Day Share Price 2026/02/10 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Adicet Bio, Inc. is covered by 12 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Justin ZelinB. Riley Securities, Inc.
John NewmanCanaccord Genuity
Michael SchmidtGuggenheim Securities, LLC